News about Clinical Trials

SMC unveils Cambridge Pharma

The new business will offer pharmaceutical development services, including sterile fill-finish

Clinical Trials | 07/09/2022 | By Sudeep Soparkar

3D model created for rare neuromuscular disorder

Scientists have created a bioengineered 3-D model that mimics the biology of two rare diseases. The researchers used the 'tissue chip' model to show how a drug could potentially treat the diseases, providing data for a drug company's FDA submission for authorization for clinical testing.

Clinical Trials | 04/05/2022 | By Sudeep Soparkar |  129

New patent grant to OSE Immunotherapeutics by EPO

OSE Immunotherapeutics receives European patent covering novel myeloid immune checkpoint target, CLEC-1 for cancer treatment

Clinical Trials | 03/05/2022 | By Sudeep Soparkar

EMA reviews gene therapy for Haemophilia B

EMA (European Medicines Agency) has started reviewing the CSL Behring's MAA for gene therapy etranacogene dezaparvovec (EtranaDez), for the patients getting treatment for Haemophila B.

Clinical Trials | 28/04/2022 | By Sudeep Soparkar |  133

ALS drug by Biogen and Ionis Pharmaceuticals fails in trials

Biogen and Ionis Pharmaceuticals were hoping to be the first to find a cure for ALS. That dream has now fizzled out with the companies calling it quits after receiving disappointing results from a phase 1 clinical trial.

Clinical Trials | 27/04/2022 | By Sudeep Soparkar

Anti-Tigit drug of Roche fails stage study

Roche's Genentech had disappointing news to share this week regarding its lung cancer hopeful.

Clinical Trials | 26/04/2022 | By Sudeep Soparkar

Funds of $130m raised for B cell medications

Be Bio raises $130m to foster designed B cell medications. As a feature of the financing, ARCH Venture Partners overseeing chief Steven Gillis will join Be Bio's governing body.

Clinical Trials | 23/04/2022 | By Sudeep Soparkar

BioXcel to develop drugs in oncology

BioXcel shapes entirely claimed auxiliary OnkosXcel to foster prescriptions centered in oncology

Clinical Trials | 21/04/2022 | By Sudeep Soparkar

IDB therapies to improve with lymphoid cell maturity

New knowledge on lymphoid cell maturity could lead to more effective IBD therapies

Clinical Trials | 18/04/2022 | By Sudeep Soparkar |  173

Effects of rilzabrutinib in individuals with insusceptible thrombocytopenia

Positive phase 1/2 study results of rilzabrutinib in people with immune thrombocytopenia published in The New England Journal of Medicine

Clinical Trials | 16/04/2022 | By Sudeep Soparkar |  130